ArticlePharmacoepidemiology and drug safety2018

Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.

Sheriza N Baksh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.